Sector consensus Marker Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 20:00:00 13/03/2026 GMT			5-day change	1st Jan Change
1.330 ^USD	-1.48%		-3.62%	-10.74%

11-14	Marker Therapeutics Q3 net loss narrows to $2 mln	RE
11-13	Marker Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
MARKER THERAPEUTICS, INC.	US$7.867	+491.48%	3
LONZA GROUP AG	CHF 675.78	+40.5%	23
BEONE MEDICINES AG	US$416.33	+46.57%	24
CELLTRION, INC.	₩253,958.33	+23.58%	24
IQVIA HOLDINGS INC.	US$236.19	+43.39%	21
REVOLUTION MEDICINES, INC.	US$129.35	+36.36%	20
ASCENDIS PHARMA A/S	US$247.03	+26.41%	16
MEDPACE HOLDINGS, INC.	US$489.69	+8.72%	13
EUROFINS SCIENTIFIC SE	€71.71	+16.63%	14
IONIS PHARMACEUTICALS, INC.	US$93.9	+31.9%	22
ABIVAX	€108.72	+7.43%	6
TEMPUS AI, INC.	US$77.93	+55.92%	14
QIAGEN N.V.	US$55.23	+36.04%	15
PRAXIS PRECISION MEDICINES, INC.	US$600.71	+104.36%	17
BIO-TECHNE CORPORATION	US$75.25	+47.98%	12
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	US$197.47	+27.02%	15
ICON PUBLIC LIMITED COMPANY	US$138.64	+41%	14
PHARMARON BEIJING CO., LTD.	CN¥37.92	+36.44%	12
Average	14,312.11	+62.32%	16
Weighted average by Cap.	28,907.3	+36.57%	19